Cargando…
Formoterol attenuates increased oxidative stress and myosin protein loss in respiratory and limb muscles of cancer cachectic rats
Muscle mass loss and wasting are characteristic features of patients with chronic conditions including cancer. Therapeutic options are still scarce. We hypothesized that cachexia-induced muscle oxidative stress may be attenuated in response to treatment with beta(2)-adrenoceptor-selective agonist fo...
Autores principales: | Salazar-Degracia, Anna, Busquets, Sílvia, Argilés, Josep M., López-Soriano, Francisco J., Barreiro, Esther |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
PeerJ Inc.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5732544/ https://www.ncbi.nlm.nih.gov/pubmed/29255650 http://dx.doi.org/10.7717/peerj.4109 |
Ejemplares similares
-
Sirtuin 1 in skeletal muscle of cachectic tumour-bearing rats: a role in impaired regeneration?
por: Toledo, Míriam, et al.
Publicado: (2011) -
The cachexia score (CASCO): a new tool for staging cachectic cancer patients
por: Argilés, Josep M., et al.
Publicado: (2011) -
Formoterol in the treatment of experimental cancer cachexia: effects on heart function
por: Toledo, Míriam, et al.
Publicado: (2014) -
A multifactorial anti‐cachectic approach for cancer cachexia in a rat model undergoing chemotherapy
por: Toledo, Míriam, et al.
Publicado: (2015) -
A comparison of budesonide/formoterol maintenance and reliever therapy vs. conventional best practice in asthma management
por: Louis, R, et al.
Publicado: (2009)